DK2707003T3 - Krystallinske salte af (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacen-2-carboxylsyreamid og fremgangsmåder til anvendelse deraf - Google Patents

Krystallinske salte af (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacen-2-carboxylsyreamid og fremgangsmåder til anvendelse deraf Download PDF

Info

Publication number
DK2707003T3
DK2707003T3 DK12782600.6T DK12782600T DK2707003T3 DK 2707003 T3 DK2707003 T3 DK 2707003T3 DK 12782600 T DK12782600 T DK 12782600T DK 2707003 T3 DK2707003 T3 DK 2707003T3
Authority
DK
Denmark
Prior art keywords
methyl
naphthacen
tetrahydroxy
octahydro
dioxo
Prior art date
Application number
DK12782600.6T
Other languages
English (en)
Inventor
Catherine Coulter
Sean M Johnston
Farzaneh Seyedi
Original Assignee
Paratek Pharm Innc
Allergan Pharmaceuticals Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharm Innc, Allergan Pharmaceuticals Int Ltd filed Critical Paratek Pharm Innc
Application granted granted Critical
Publication of DK2707003T3 publication Critical patent/DK2707003T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
DK12782600.6T 2011-05-12 2012-05-14 Krystallinske salte af (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacen-2-carboxylsyreamid og fremgangsmåder til anvendelse deraf DK2707003T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161485179P 2011-05-12 2011-05-12
PCT/US2012/037838 WO2012155146A1 (en) 2011-05-12 2012-05-14 Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same

Publications (1)

Publication Number Publication Date
DK2707003T3 true DK2707003T3 (da) 2019-08-05

Family

ID=47139728

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12782600.6T DK2707003T3 (da) 2011-05-12 2012-05-14 Krystallinske salte af (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacen-2-carboxylsyreamid og fremgangsmåder til anvendelse deraf

Country Status (14)

Country Link
US (4) US9255068B2 (da)
EP (2) EP2707003B1 (da)
JP (5) JP6574572B2 (da)
CA (1) CA2835876C (da)
DK (1) DK2707003T3 (da)
ES (1) ES2739626T3 (da)
HR (1) HRP20191295T8 (da)
HU (1) HUE044536T2 (da)
LT (1) LT2707003T (da)
PL (1) PL2707003T3 (da)
PT (1) PT2707003T (da)
SI (1) SI2707003T1 (da)
TR (1) TR201911086T4 (da)
WO (1) WO2012155146A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8856782B2 (en) 2007-03-01 2014-10-07 George Mason Research Foundation, Inc. On-demand disposable virtual work system
US9098698B2 (en) 2008-09-12 2015-08-04 George Mason Research Foundation, Inc. Methods and apparatus for application isolation
HUE044536T2 (hu) * 2011-05-12 2019-10-28 Paratek Pharm Innc A (4S,4aS,5aR,12aS)-4-dimetilamino-3,10,12,12a-tetrahidroxi-7-[(metoxi(metil)amino)-metil]- 1,11-dioxo-1,4,4a,5,5a,6,11,12a-oktahidro-naftacén-2-karbonsav amid és alkalmazási módszerei
CA2873412A1 (en) * 2012-05-14 2013-11-21 Paratek Pharmaceuticals, Inc. Methods of using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide
JP2019531321A (ja) * 2016-10-19 2019-10-31 テトラフェース ファーマシューティカルズ，インコーポレイテッド エラバサイクリンの結晶形
MA49641A (fr) * 2017-07-21 2021-06-02 Almirall Llc Traitement de lésions non inflammatoires
JP7418345B2 (ja) * 2018-04-06 2024-01-19 パラテック ファーマシューティカルズ，インコーポレイテッド サレサイクリン塩酸塩を製造する方法
WO2022265026A1 (ja) 2021-06-14 2022-12-22 日置電機株式会社 短絡検出装置及び短絡検出方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
NL6607516A (da) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
CA2103189C (en) 1992-11-17 2005-05-03 Lorne M. Golub Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes
EP0745065A1 (en) 1994-02-17 1996-12-04 Pfizer Inc. 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5789395A (en) 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US6277061B1 (en) 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
ES2701725T3 (es) 2006-12-21 2019-02-25 Paratek Pharm Innc Compuestos de tetraciclina sustituida para el tratamiento de trastornos inflamatorios de la piel
KR101538175B1 (ko) * 2006-12-21 2015-07-20 파라테크 파마슈티컬스, 인크. 박테리아, 바이러스 및 기생충 감염의 치료를 위한 테트라시클린 유도체
WO2009111064A2 (en) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
TWI585071B (zh) * 2008-05-23 2017-06-01 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
HUE044536T2 (hu) * 2011-05-12 2019-10-28 Paratek Pharm Innc A (4S,4aS,5aR,12aS)-4-dimetilamino-3,10,12,12a-tetrahidroxi-7-[(metoxi(metil)amino)-metil]- 1,11-dioxo-1,4,4a,5,5a,6,11,12a-oktahidro-naftacén-2-karbonsav amid és alkalmazási módszerei
CA2873412A1 (en) * 2012-05-14 2013-11-21 Paratek Pharmaceuticals, Inc. Methods of using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide

Also Published As

Publication number Publication date
EP3574908A1 (en) 2019-12-04
JP2019142867A (ja) 2019-08-29
US20190040002A1 (en) 2019-02-07
JP2023093519A (ja) 2023-07-04
JP2014520077A (ja) 2014-08-21
WO2012155146A1 (en) 2012-11-15
HUE044536T2 (hu) 2019-10-28
US20160200671A1 (en) 2016-07-14
JP2021098695A (ja) 2021-07-01
SI2707003T1 (sl) 2019-10-30
EP2707003B1 (en) 2019-05-01
HRP20191295T8 (hr) 2020-02-07
EP2707003A1 (en) 2014-03-19
JP2017132775A (ja) 2017-08-03
CA2835876C (en) 2020-04-14
JP6574572B2 (ja) 2019-09-11
PT2707003T (pt) 2019-08-05
LT2707003T (lt) 2019-10-10
PL2707003T3 (pl) 2019-11-29
HRP20191295T1 (hr) 2019-10-18
EP2707003A4 (en) 2014-11-12
US20200024223A1 (en) 2020-01-23
US20130012480A1 (en) 2013-01-10
JP6876082B2 (ja) 2021-05-26
CA2835876A1 (en) 2012-11-15
US9255068B2 (en) 2016-02-09
TR201911086T4 (tr) 2019-08-21
ES2739626T3 (es) 2020-02-03

Similar Documents

Publication Publication Date Title
DK2707003T3 (da) Krystallinske salte af (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacen-2-carboxylsyreamid og fremgangsmåder til anvendelse deraf
DK3238709T3 (da) Forbedrede parenterale formuleringer af lipofile farmaceutiske midler og fremgangsmåder til fremstilling og anvendelse af samme
SMT201400142B (it) Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms
DK2429417T3 (da) Apparat til påføring af kirurgisk fastgørelseselement
DK3170821T3 (da) Sammensætninger som indeholder, fremgangsmåder som involverer, og anvendelser af ikke-naturlige aminosyrebundne dolastatinderivater
DK2489670T3 (da) Fremgangsmåde til fremstilling af aminosyre-chelatforbindelser, aminosyre-chelatforbindelser og anvendelse af aminosyre-chelatforbindelser
SMT201600013B (it) Procedimento per la preparazione di acidi, esteri e ammidi [(3-idrossipiridin-2-carbonil) ammino]alcanoici
DK2451771T3 (da) Salte af rasagilin og farmaceutiske fremstillingsmåder heraf
DK3378862T3 (da) Dihydropyrimidinoisoquinolinoner og farmaceutiske sammensætninger deraf til behandlingen af multipel sklerose
BR112014001346A2 (pt) composto nanotransportador, método, composto farmacêutico e uso de um composto
LT2688885T (lt) N-(1,3,4-oksadiazol-2-il)arilkarboksamidai ir jų panaudojimas kaip herbicidų
DK2704703T3 (da) Transdermale sammensætninger af ibuprofen og fremgangsmåder til anvendelse deraf
DK2627233T3 (da) Fremgangsmåde til drift af en rengøringsindretning og rengøringsindretning til gennemførelse af fremgangsmåden
CO7020907A2 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
DK2966058T3 (da) Nye calciumsalte af forbindelse som anti-inflammatoriske, immunomodulatoriske og anti-profliferative midler
DK2734212T3 (da) Sammensætninger omfattende diclofenac til behandling af postoperativ smerte
WO2013150545A8 (en) Process for preparation of benzimidazole derivatives and salts thereof
ITMI20111894A1 (it) Apparecchio per la ritenuta di pezzi
AP2015008407A0 (en) N-(2-(cyclic amine)ethyl) benzamide derivatives asP2X7 inhibitors
DK2486945T3 (da) Fremgangsmåde og indretning til rengøring af medicinske instrumenter
DK2402306T3 (da) Fremgangsmåde til fremstilling af 5-aminolaevulinsyrehydrochlorid
DK2215050T3 (da) Fremgangsmåde til fremstilling af 2-hydroxy-5-phenylalkylaminobenzoesyrederivater og salte deraf
EP2849757A4 (en) PROCESS FOR USE OF (4S, 4AS, 5AR, 12AS -) - 4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7 - [(METHOXY (METHYL) AMINO) -METHYL] -1,11-DIOXO-1 , 4.4A, 5.5A, 6,11,12a-octahydro-naphthacene-2-carboxylic acid amide
DK2487158T3 (da) Ny fremgangsmåde til syntetisering af ivabradin og dets additionssalte med en farmaceutisk acceptabel syre
CL2013000797A1 (es) Proceso de preparacion de (2r,3r)-3-{4-(s-(ciclo)alquil-sulfonimidoil)fenil}amino}-5-(trifluorometil)pirimidin-4-il}oxi}butan-2-2ol inhibidores; y los compuestos intermediarios considerados.